Drug · DIN 02492415
BAQSIMI
SINGLE-DOSE DEVICE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 23, 2024; first marketed November 20, 2019.
- Drug Identification Number (DIN)
- 02492415
- Company (DIN owner)
- Amphastar Pharmaceuticals IncRancho Cucamonga, California, United States
- Schedule
- Ethical
- Dosage form
- Powder
- Route
- Nasal
- Therapeutic class (ATC)
- Glucagon H04AA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GLUCAGON | 3 MG | CONTAINER |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 14, 2024: NOC 32701New Drug Submission (NDS) · Administrative: Change in Product Ownership
- September 25, 2019: NOC 22694New Drug Submission (NDS)